Negócios · 30/05/20251 min de leitura
Meda AB and B. Braun Medical, Inc.; Withdrawal of Approval of Two New Drug Applications
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA or Agency) is withdrawing approval of two new drug applications (NDAs) from two applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.